Faculty of Life Sciences, University of Manchester, 3.614 Stopford Building, Oxford Road, Manchester M13 9PT, UK.
Exp Physiol. 2012 Jun;97(6):785-95. doi: 10.1113/expphysiol.2011.063172. Epub 2012 Feb 10.
Urotensin II (UII), a peptide hormone which influences glomerular filtration rate and urine concentration, and its receptor, UT, are expressed in the adult rat kidney. The ability of the kidney to reabsorb sodium and water starts to develop in utero and matures during early postnatal life in the rat, yet little is known about the ontogeny of the renal UII system. This study mapped renal expression of the urotensin system during the fetal and postnatal periods and determined renal activity of UII in the immature rat. Urotensin II peptide and mRNA were present in Sprague-Dawley (SD) rat metanephroi from the earliest stage examined, embyonic day 19 (E19; rat gestation 22 days); levels increased to peak at 4 weeks of age. In contrast, UT protein and mRNA expression declined rapidly between E19 and birth and remained at a similar level postnatally. Infusion of rat UII [6-60 pmol min(-1) (100 g body weight)(-1)] or rat urotensin-related peptide [6 pmol min(-1) (100 g body weight)(-1)] in anaesthetized 4-week-old SD rats had no influence on measured renal parameters; however, infusion of UT antagonist, SB-706375 (0.01 mg kg(-1) min(-1)), provoked a pronounced diuresis [vehicle 23.5 ± 1.9 versus antagonist 75.3 ± 12.5 μl min(-1) (100 g body weight)(-1); P < 0.001] and natriuresis, accompanied by modest increases in effective renal blood flow and glomerular filtration rate [vehicle 0.4 ± 0.1 versus antagonist 1.1 ± 0.2 ml min(-1) (100 g body weight)(-1); P < 0.0001] and a significant increase in fractional sodium excretion. These results indicate that the endogenous rat UII system may influence renal sodium and water excretion before the onset of full urine concentrating capacity in the SD rat.
尿鸟素 II(UII)是一种影响肾小球滤过率和尿液浓缩的肽类激素,其受体 UT 在成年大鼠肾脏中表达。肾脏重吸收钠和水的能力在宫内开始发育,并在大鼠出生后的早期阶段成熟,但关于肾脏 UII 系统的个体发生知之甚少。本研究描绘了胎儿和出生后肾脏 UII 系统的表达,并确定了未成熟大鼠肾脏中 UII 的活性。Urotensin II 肽和 mRNA 存在于 Sprague-Dawley(SD)大鼠的中肾从最早检查的胚胎期 19 天(E19;大鼠妊娠 22 天);水平在 4 周龄时达到高峰。相比之下,UT 蛋白和 mRNA 表达在 E19 和出生之间迅速下降,并在出生后保持相似水平。在麻醉的 4 周龄 SD 大鼠中输注大鼠 UII [6-60 pmol min(-1)(100 g 体重)(-1)]或大鼠尿鸟素相关肽 [6 pmol min(-1)(100 g 体重)(-1)]对测量的肾脏参数没有影响;然而,输注 UT 拮抗剂 SB-706375(0.01 mg kg(-1) min(-1)))引起明显的利尿作用[载体 23.5 ± 1.9 与拮抗剂 75.3 ± 12.5 μl min(-1)(100 g 体重)(-1);P < 0.001]和尿钠排泄增加,同时有效肾血流量和肾小球滤过率略有增加[载体 0.4 ± 0.1 与拮抗剂 1.1 ± 0.2 ml min(-1)(100 g 体重)(-1);P < 0.0001],以及钠排泄分数的显著增加。这些结果表明,内源性大鼠 UII 系统可能在 SD 大鼠完全浓缩尿液能力出现之前影响肾脏钠和水的排泄。